1
2
PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis
by Mestre, L, Redondo, M, Carrillo-Salinas, F J, Morales-García, J A, Alonso-Gil, S, Pérez-Castillo, A, Gil, C, Martínez, A, Guaza, C
Published in Br J Pharmacol (2015)
Get full textPublished in Br J Pharmacol (2015)
Get full text
Get full text
Artigo
3
by Carrillo-Salinas, F. J., Mestre, L., Mecha, M., Feliú, A., del Campo, R., Villarrubia, N., Espejo, C., Montalbán, X., Álvarez-Cermeño, J. C., Villar, L. M., Guaza, C.
Published in Sci Rep (2017)
Get full textPublished in Sci Rep (2017)
Get full text
Get full text
Artigo
4
by Barlow, J., Gardner, T. A., Araujo, I. S., Ávila-Pires, T. C., Bonaldo, A. B., Costa, J. E., Esposito, M. C., Ferreira, L. V., Hawes, J., Hernandez, M. I. M., Hoogmoed, M. S., Leite, R. N., Lo-Man-Hung, N. F., Malcolm, J. R., Martins, M. B., Mestre, L. A. M., Miranda-Santos, R., Nunes-Gutjahr, A. L., Overal, W. L., Parry, L., Peters, S. L., Ribeiro-Junior, M. A., da Silva, M. N. F., da Silva Motta, C., Peres, C. A.
Published 2007
Get full textPublished 2007
Get full text
Get full text
Artigo